Logo image of FEMY

FEMASYS INC (FEMY) Stock Fundamental Analysis

USA - NASDAQ:FEMY - US31447E1055 - Common Stock

0.7963 USD
-0.1 (-11.28%)
Last: 11/17/2025, 5:20:00 PM
0.812 USD
+0.02 (+1.97%)
After Hours: 11/17/2025, 5:20:00 PM
Fundamental Rating

2

Overall FEMY gets a fundamental rating of 2 out of 10. We evaluated FEMY against 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of FEMY have multiple concerns. FEMY is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year FEMY has reported negative net income.
FEMY had a negative operating cash flow in the past year.
In the past 5 years FEMY always reported negative net income.
In the past 5 years FEMY always reported negative operating cash flow.
FEMY Yearly Net Income VS EBIT VS OCF VS FCFFEMY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -150.14%, FEMY is doing worse than 87.23% of the companies in the same industry.
With a Return On Equity value of -1392.05%, FEMY is not doing good in the industry: 88.30% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -150.14%
ROE -1392.05%
ROIC N/A
ROA(3y)-91.91%
ROA(5y)-78.58%
ROE(3y)-326.2%
ROE(5y)-240.6%
ROIC(3y)N/A
ROIC(5y)N/A
FEMY Yearly ROA, ROE, ROICFEMY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

1.3 Margins

With a decent Gross Margin value of 65.09%, FEMY is doing good in the industry, outperforming 69.15% of the companies in the same industry.
FEMY's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for FEMY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y-2.71%
FEMY Yearly Profit, Operating, Gross MarginsFEMY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -500 -1K

0

2. Health

2.1 Basic Checks

FEMY does not have a ROIC to compare to the WACC, probably because it is not profitable.
FEMY has more shares outstanding than it did 1 year ago.
The number of shares outstanding for FEMY has been increased compared to 5 years ago.
Compared to 1 year ago, FEMY has a worse debt to assets ratio.
FEMY Yearly Shares OutstandingFEMY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
FEMY Yearly Total Debt VS Total AssetsFEMY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of -16.16, we must say that FEMY is in the distress zone and has some risk of bankruptcy.
FEMY's Altman-Z score of -16.16 is on the low side compared to the rest of the industry. FEMY is outperformed by 84.04% of its industry peers.
A Debt/Equity ratio of 4.03 is on the high side and indicates that FEMY has dependencies on debt financing.
FEMY's Debt to Equity ratio of 4.03 is on the low side compared to the rest of the industry. FEMY is outperformed by 86.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.03
Debt/FCF N/A
Altman-Z -16.16
ROIC/WACCN/A
WACC7.92%
FEMY Yearly LT Debt VS Equity VS FCFFEMY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

FEMY has a Current Ratio of 0.89. This is a bad value and indicates that FEMY is not financially healthy enough and could expect problems in meeting its short term obligations.
FEMY has a worse Current ratio (0.89) than 90.43% of its industry peers.
A Quick Ratio of 0.41 indicates that FEMY may have some problems paying its short term obligations.
FEMY's Quick ratio of 0.41 is on the low side compared to the rest of the industry. FEMY is outperformed by 93.62% of its industry peers.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.41
FEMY Yearly Current Assets VS Current LiabilitesFEMY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

6

3. Growth

3.1 Past

The earnings per share for FEMY have decreased by -2.41% in the last year.
The Revenue has grown by 98.62% in the past year. This is a very strong growth!
The Revenue has been growing by 11.86% on average over the past years. This is quite good.
EPS 1Y (TTM)-2.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
Revenue 1Y (TTM)98.62%
Revenue growth 3Y11.35%
Revenue growth 5Y11.86%
Sales Q2Q%112.22%

3.2 Future

Based on estimates for the next years, FEMY will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.14% on average per year.
Based on estimates for the next years, FEMY will show a very strong growth in Revenue. The Revenue will grow by 109.73% on average per year.
EPS Next Y29.2%
EPS Next 2Y28.53%
EPS Next 3Y19.91%
EPS Next 5Y15.14%
Revenue Next Year8.11%
Revenue Next 2Y67.18%
Revenue Next 3Y126.15%
Revenue Next 5Y109.73%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FEMY Yearly Revenue VS EstimatesFEMY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
FEMY Yearly EPS VS EstimatesFEMY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.2 -0.4 -0.6 -0.8 -1

0

4. Valuation

4.1 Price/Earnings Ratio

FEMY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year FEMY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FEMY Price Earnings VS Forward Price EarningsFEMY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FEMY Per share dataFEMY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

FEMY's earnings are expected to grow with 19.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.53%
EPS Next 3Y19.91%

0

5. Dividend

5.1 Amount

No dividends for FEMY!.
Industry RankSector Rank
Dividend Yield N/A

FEMASYS INC

NASDAQ:FEMY (11/17/2025, 5:20:00 PM)

After market: 0.812 +0.02 (+1.97%)

0.7963

-0.1 (-11.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06 2025-11-06
Earnings (Next)03-25 2026-03-25/amc
Inst Owners14.09%
Inst Owner Change-26.09%
Ins Owners11.44%
Ins Owner Change35.82%
Market Cap34.25M
Revenue(TTM)1.89M
Net Income(TTM)-21.02M
Analysts82.22
Price Target6.38 (701.21%)
Short Float %9.16%
Short Ratio0.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.19%
Min EPS beat(2)-18.68%
Max EPS beat(2)18.3%
EPS beat(4)1
Avg EPS beat(4)-9.98%
Min EPS beat(4)-21.89%
Max EPS beat(4)18.3%
EPS beat(8)3
Avg EPS beat(8)-5.92%
EPS beat(12)5
Avg EPS beat(12)-4.03%
EPS beat(16)7
Avg EPS beat(16)-0.14%
Revenue beat(2)0
Avg Revenue beat(2)-62.91%
Min Revenue beat(2)-70.71%
Max Revenue beat(2)-55.12%
Revenue beat(4)0
Avg Revenue beat(4)-51.94%
Min Revenue beat(4)-70.71%
Max Revenue beat(4)-16.58%
Revenue beat(8)0
Avg Revenue beat(8)-46.57%
Revenue beat(12)1
Avg Revenue beat(12)-34.57%
Revenue beat(16)3
Avg Revenue beat(16)-25.25%
PT rev (1m)0%
PT rev (3m)-13.79%
EPS NQ rev (1m)-4%
EPS NQ rev (3m)-4%
EPS NY rev (1m)0%
EPS NY rev (3m)7.09%
Revenue NQ rev (1m)8.75%
Revenue NQ rev (3m)8.75%
Revenue NY rev (1m)-10.77%
Revenue NY rev (3m)-52.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 18.15
P/FCF N/A
P/OCF N/A
P/B 17.12
P/tB 17.65
EV/EBITDA N/A
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-0.46
FCFYN/A
OCF(TTM)-0.45
OCFYN/A
SpS0.04
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -150.14%
ROE -1392.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.09%
FCFM N/A
ROA(3y)-91.91%
ROA(5y)-78.58%
ROE(3y)-326.2%
ROE(5y)-240.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y-2.71%
F-Score3
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 4.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 217.58%
Cap/Sales 39.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.89
Quick Ratio 0.41
Altman-Z -16.16
F-Score3
WACC7.92%
ROIC/WACCN/A
Cap/Depr(3y)128.47%
Cap/Depr(5y)88.48%
Cap/Sales(3y)33.04%
Cap/Sales(5y)25.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
EPS Next Y29.2%
EPS Next 2Y28.53%
EPS Next 3Y19.91%
EPS Next 5Y15.14%
Revenue 1Y (TTM)98.62%
Revenue growth 3Y11.35%
Revenue growth 5Y11.86%
Sales Q2Q%112.22%
Revenue Next Year8.11%
Revenue Next 2Y67.18%
Revenue Next 3Y126.15%
Revenue Next 5Y109.73%
EBIT growth 1Y-16.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-78.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-74.98%
OCF growth 3YN/A
OCF growth 5YN/A

FEMASYS INC / FEMY FAQ

What is the ChartMill fundamental rating of FEMASYS INC (FEMY) stock?

ChartMill assigns a fundamental rating of 2 / 10 to FEMY.


Can you provide the valuation status for FEMASYS INC?

ChartMill assigns a valuation rating of 0 / 10 to FEMASYS INC (FEMY). This can be considered as Overvalued.


Can you provide the profitability details for FEMASYS INC?

FEMASYS INC (FEMY) has a profitability rating of 1 / 10.


How financially healthy is FEMASYS INC?

The financial health rating of FEMASYS INC (FEMY) is 0 / 10.


What is the earnings growth outlook for FEMASYS INC?

The Earnings per Share (EPS) of FEMASYS INC (FEMY) is expected to grow by 29.2% in the next year.